Accordingly, SC-derived progenitors of both TD children and CP patients led to varying levels of protein expression for MYOD (Figure 3B, day 0; arrows and arrowheads) and consequently for MyHC, upon differentiation (Figure 3B, day 6). The gene discussed is MYH6; the disease is thanatophoric dysplasia.